MedTrace Logo

Use of Airpod Pros as Assistive Technology

NCT06840015 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-05-11

No results posted yet for this study

Summary

The goal of this study is to investigate the suitability and effectiveness of the AirPod Pro 2nd and 3rd generation (AP) as hearing assistive technology for individuals with mild-to-moderate hearing loss when listening in noisy environments. Researchers will compare four types of assistive technology: hearing aids (HAs), AP, dedicated wireless remote microphones, and Smartphone wireless remote microphone.

The main questions it aims to answer are:

* Which assistive technology provides the greatest benefit for speech recognition in noisy environments?
* How do these devices impact listening effort, as measured by reaction time in a dual-task activity and changes in pupil size?
* What are participants' preferences for each device based on how easy it is to understand speech and their overall satisfaction? Participants will visit the lab for a single 3-hour session. They will listen to sentences using each device and repeat what they hear. During this task, their reaction times for the secondary task and changes in pupil size will be measured.

Conditions

  • Hearing Loss, Adult-Onset
  • Hearing Aids

Interventions

DEVICE

Airpod Pro as hearing assistive technology

All participants will use and evaluate four types of assistive technology: hearing aids, Airpod pro 2nd and 3rd generation, dedicated wireless remote microphones, and Smartphone wireless remote microphone.

Sponsors & Collaborators

  • The University of Texas at Dallas

    lead OTHER

Principal Investigators

  • Linda Thibodeau, Ph.D. · The University of Texas at Dallas

  • Seeon Kim, Ph.D. · Callier Center for Communication Disorders

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-07-31
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06840015 on ClinicalTrials.gov